ArticlePersonalized medicine2012
After the revolution? Ethical and social challenges in 'personalized genomic medicine'
Article in Personalized medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Inadvertent human genomic bycatch and intentional capture raise beneficial applications and ethical concerns with environmental DNA.Nature ecology & evolution · 2023Article
- Adapting a conceptual framework to engage diverse stakeholders in genomic/precision medicine research.Health expectations : an international journal of public participation in health care and health policy · 2022Article
- Investigating acceptability of a training programme in precision medicine for frontline healthcare professionals: a mixed methods study.BMC medical education · 2022Review
- Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes.The EPMA journal · 2021Review
- Governing Personalized Health: A Scoping Review.Frontiers in genetics · 2021Article
- Genomic Essentialism: Its Provenance and Trajectory as an Anticipatory Ethical Concern.The Hastings Center report · 2019Article
- [France and Great-Britain at the age of genomic medicine: new ethical challenges in reproductive medicine].Medecine sciences : M/S · 2019Article
- Help, hope and hype: ethical considerations of human microbiome research and applications.Protein & cell · 2018Article
- From "Personalized" to "Precision" Medicine: The Ethical and Social Implications of Rhetorical Reform in Genomic Medicine.The Hastings Center report · 2016Article
- The new holism: P4 systems medicine and the medicalization of health and life itself.Medicine, health care, and philosophy · 2016Article
- Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.Urologic oncology · 2014Article
- Essential elements of personalized medicine.Urologic oncology · 2014Article
- Article
- National Institutes of Health Center for Regenerative Medicine: putting science into practice.Stem cells and development · 2013Article
- Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.PLoS biology · 2013Article
- Team Learning for Healthcare Quality Improvement.IEEE access : practical innovations, open solutions · 2013Article
- The changing landscape of carrier screening: expanding technology and options?.Health matrix (Cleveland, Ohio : 1991) · 2013Article
- P4 medicine: how systems medicine will transform the healthcare sector and society.Personalized medicine · 2013Article
- Personalized genomic medicine and the rhetoric of empowerment.The Hastings Center reportArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Personalized genomic medicine (PGM) is a goal that currently unites a wide array of biomedical initiatives, and is promoted as a 'new paradigm for healthcare' by its champions. Its promissory virtues include individualized diagnosis and risk prediction, more effective prevention and health promotion, and patient empowerment. Beyond overcoming scientific and technological hurdles to realizing PGM, proponents may interpret and rank these promises differently, which carries ethical and social implications for the realization of PGM as an approach to healthcare. We examine competing visions of PGM's virtues and the directions in which they could take the field, in order to anticipate policy choices that may lie ahead for researchers, healthcare providers and the public.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.